Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 80, Issue 1, 2008, Pages

  Fujita, Yoshihito ^a   Fukushima, Mitsuo ^a,b   Suzuki, Haruhiko ^a   Taniguchi, Ataru ^c   Nakai, Yoshikatsu ^a   Kuroe, Akira ^c   Yasuda, Koichiro ^a   Hosokawa, Masaya ^a   Yamada, Yuichiro ^a   Inagaki, Nobuya ^a   Seino, Yutaka ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c Kansai Denryoku Hospital   (Japan)

Author keywords

Diabetic peripheral neuropathy; Glucose metabolism; Glycemic control; Lipid metabolism; Vibratory sensation

Indexed keywords

CHOLESTEROL; FATTY ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC NEUROPATHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; STATISTICAL ANALYSIS; VIBRATION SENSE;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NEURONS, AFFERENT; RECOVERY OF FUNCTION; VIBRATION;

EID: 40849106371     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.12.011     Document Type: Article

References (19)

1. The Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng. J. Med. 329 (1993) 977-986
2. The Diabetes Control Complications Trial Research Group. Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann. Neurol. 38 (1995) 869-880
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33). Lancet 352 (1998) 837-853
4. Ohkubo Y., Kishikawa H., Eiichi A., Miyata T., Isami A., Motoyoshi S., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
5. Service F.J., Rizza R.A., Daube J.R., O'Brien P.C., and Dyck P.J. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28 (1985) 722-727
6. Pestronk A., Florence J., Levine T., Al-Lozi, Lopate G., Miller T., et al. Sensory exam with a quantitative tuning fork. Neurology 62 (2004) 461-464
7. Martina I.S.J., van koningsveld R., Schmitz P.I.M., van der Meche F.G.A., and van Doorn P.A. For the European inflammatory neuropathy cause and treatment INCAT) group, Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. J. Neurol. Neurosurg. Psychiatry 65 (1998) 743-747
8. Shichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetes patients. Diabetes Care 23 Suppl. 2 (2000) B21-B29
9. Goto Y., Hotta N., Shigeta Y., Sakamoto N., and Kikkawa R. Effects of aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study. Biomed. Pharmacother. 49 (1995) 269-277
10. Hotta N., Sugimura K., Tsuchida I., Sano T., Koh N., Matsumae H., et al. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy. Clin. Ther. 16 (1994) 1007-1015
11. Taniguchi A., Fukushima M., Sakai M., Miwa K., Makita T., Nagata I., et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 23 (2000) 1766-1769
12. Fukushima M., Usami M., Ikeda M., Nakai Y., Taniguchi A., Matsuura T., et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 53 (2004) 831-835
13. Sima A.A., and Laudadio C. Design of controlled clinical trials for diabetic polyneuropathy. Semin. Neurol. 16 (1996) 187-191
14. James M., Kennedy, Douglas W., and Zochodne. Experimental diabetic neuropathy with spontaneous recovery. Is there irreparable damage?. Diabetes 54 (2005) 830-837
15. Britland S.T., Young R.J., Sharma A.K., and Clarke B.F. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 39 (1990) 898-908
16. Meijer J.W., Smit A.J., Sonderen E.V., Groothoff J.W., Eisma W.H., and Links T.P. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the diabetic neuropathy symptom score. Diabet. Med. 19 (2002) 962-965
17. Yagihashi S. Pathology and pathogenic mechanism of diabetic neuropathy. Diabetes Metab. Rev. 11 (1995) 193-225
18. Thrainsdottir S., Malik R.A., Dahlin L.B., Wiksell P., Eriksson K.F., Rosén I., Petersson J., Greene D.A., and Sundkvist G. Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 52 (2003) 2615-2622
19. Hughes R.A.C., Umapathi T., Gray I.A., Gregson N.A., Noori M., Pannala A.S., et al. A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain 127 (2004) 1723-1730